HiLung was founded in 2020 to dramatically accelerate respiratory drug discovery and development, based on our pioneering cell differentiation technologies which can mass-produce respiratory cells from human stem cells, including human iPSCs (induced pluripotent stem cells) –unprecedented industry-scale yield of which positions us at the forefront of R&D in respiratory cell & organoid biology.
All through our leading efforts, we strive to contribute to a future where all respiratory diseases can be cured and "Everybody Is Happily Inspiring".
Company Details
- Employees
- 9
- Founded
- -
- Address
- 46-29, Yoshida-Shimo-Adachi-Cho, Sakyo-Ku, Kyoto,kyoto 606-8304,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.hilung.com/en/
- Keywords
- SPIDER.
- HQ
- Kyoto, Kyoto
Hilung Inc. Questions
Hilung Inc.'s website is https://www.hilung.com/en/
Hilung Inc.'s LinkedIn profile is https://jp.linkedin.com/company/hilung-inc
Hilung Inc. has
9 employees.
View email and phone details for 9
employees at Hilung Inc..
Hilung Inc.'s industry is
Biotechnology Research
Hilung Inc.'s top competitors are
Applied Biological Materials,
Nigerian Red Cross Society Hq,
South Dakota Board Of Regents,
Rege Nephro Co., Ltd.,
Epithelix,
Ipszürich,
Diasome Pharmaceuticals, Inc.,
Mepsgen,
Snbl,
Spider.
Hilung Inc.'s categories are Biotechnology Research
Hilung Inc.'s founding year is 2020
